Integrating AI with care: FDA reveals focus areas for forthcoming guidance on AI products
Posted:
The FDA is focusing on integrating #AI with care, outlining key areas for forthcoming guidance on AI products. As AI technology expands, it's crucial to ensure safe implementation.
In Bold Insight latest blog, Stephanie Wiltman breaks down the FDA's focus areas and how they'll shape the future of AI in healthcare.
Antimicrobial resistance could claim almost two million lives a year by 2050. Now, researchers believe they could use #AI to predict which bugs will become resistant so that we can better prepare.
Read the full article here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…